Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Roche wins European approval for new leukaemia drug

Roche wins European approval for new leukaemia drug Roche's existing interests in blood cancer include MabThera/Herceptin (rituximab), which has been a big success for the company but is set to face competition from biosimilar versions due to

Highlighting the Cancer Capacity Challenge

Furthermore, the subsequent launch campaign for Herceptin subcut saw messaging about the role the innovative new treatment could play in easing the chemotherapy burden in nearly two thirds of coverage.

Niche-busting cancer immunotherapies

Niche-busting cancer immunotherapies Roche/Genentech's Herceptin and Rituxan, monoclonal antibodies that block receptors on cell surfaces, have significantly improved patient outcomes for certain breast and haematologic malignancies, respectively.

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer Of the few ADCs to have hit the market so far, the most promising is Roche's much-touted follow up to Herceptin (trastuzumab) Kadcyla, which combines the antibody Herceptin with

Creating a brand identity for biosimilars

Creating a brand identity for biosimilars Next in line will be biosimilar versions of big-selling biologics Herceptin, Enbrel, Humira, Avastin and Lantus. ... Research-based pharma companies see them as a threat to innovation and fight against them (as Roche did against the Indian company Biocon,

[ Previous 5 results ] 18 19 20 21 22 23 24 25 26 27 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...